BHC
CO

Bowen Hanes & Co’s Global Cord Blood Corporation CO Stock Holding History

Bowen Hanes & Co’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,900
Closed -$132K – 150
2017
Q3 		$132K Buy
+11,900
New +$139K 0.01% 145

Other funds holding CO

JCM
Jayhawk Capital Management Shawnee, Kansas $59.9M AUM 22.48% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Bowen Hanes & Co's CO Position: Q4 2017 in Review

Bowen Hanes & Co sold out of Global Cord Blood Corporation (CO) in Q4 2017, closing a stake of 11,900 shares — an estimated $132K sold.

Bowen Hanes & Co first reported a position in CO in Q3 2017 and held it in 1 quarter. The position peaked at $132K in Q3 2017. 50 funds tracked by Wall St. Rank hold CO as of Q4 2017.

  • Bowen Hanes & Co reported no remaining Global Cord Blood Corporation position as of Q4 2017 after selling out during the quarter.
  • Bowen Hanes & Co sold 11,900 Global Cord Blood Corporation shares in Q4 2017, an estimated $132K.
  • Bowen Hanes & Co first reported a position in Global Cord Blood Corporation in Q3 2017 and held it in 1 quarter.
  • Bowen Hanes & Co's Global Cord Blood Corporation position peaked at $132K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q4 2017.

Based on Bowen Hanes & Co's 13F filing for Q4 2017, filed 13 Feb 2018.